Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Medical Genetics

Do I Need Treatment For SPCD If I Have No Symptoms?

At a Glance

Asymptomatic adults diagnosed with Systemic Primary Carnitine Deficiency (SPCD) still require lifelong L-carnitine treatment. Even if you feel perfectly healthy, untreated SPCD can cause silent, life-threatening heart complications like sudden cardiac death during times of illness or stress.

If you have been diagnosed with Systemic Primary Carnitine Deficiency (SPCD) but feel completely healthy, you still need treatment. Many adults are diagnosed with SPCD unexpectedly—often after their baby’s newborn screening results show a potential issue [1][2]. It is entirely normal to wonder if medication is truly necessary when you have no symptoms, but medical experts strongly advise that lifelong L-carnitine supplementation is still required [3][1][4]. SPCD can cause severe, life-threatening complications that often strike without warning, making preventative treatment essential.

(Note: If you were diagnosed via your baby’s newborn screen, your baby will also need a separate evaluation by a pediatrician or metabolic specialist, as they may have a true deficiency or simply reflect your low levels [5].)

The Hidden Risks of Untreated SPCD

Carnitine is a natural substance that helps your body turn fat into energy. In SPCD, a genetic mutation prevents your body from holding onto carnitine, causing levels in your blood and tissues to drop dangerously low [6][1].

It can be a huge psychological shock to go from feeling like a healthy, active person to reading that you might be at risk for a serious cardiac event. But understanding these hidden risks is the first step in protecting yourself. Even if you currently feel fine, untreated SPCD carries a high risk of sudden cardiac death (unexpected death caused by loss of heart function), particularly in females [1][7][2]. Women are frequently diagnosed and uniquely at risk because pregnancy heavily stresses the body’s energy demands and further depletes carnitine levels, leading to a metabolic crisis [1][8].

A carnitine deficiency can weaken your heart muscle—a condition known as cardiomyopathy [9][10]—and disrupt your heart’s electrical system, causing severe arrhythmias (irregular heartbeats) [9][7].

These heart issues can develop silently. You might feel perfectly healthy until a stressful event suddenly increases your body’s energy demands and triggers a dangerous cardiac event [11]. These triggers can include illness, emotional stress, fasting, or intense physical activity [11]. While awaiting your specialist evaluation, it is wise to discuss with your doctor whether you should temporarily dial back intense exercise routines to play it safe.

Why Treatment is Crucial

The standard of care for SPCD is lifelong supplementation with L-carnitine [6][3]. L-carnitine is typically taken as a daily oral supplement, either as a pill or a liquid [12]. By taking L-carnitine daily, you replenish your body’s levels and ensure your heart and muscles have the energy they need to function safely [3][4].

Treatment is highly effective. For asymptomatic adults, consistently taking L-carnitine is the most reliable way to prevent serious cardiac and metabolic complications from ever happening [1][5].

Managing Potential Side Effects

It is natural to be skeptical about taking medication when you feel fine, especially when weighing the pros and cons. While L-carnitine is generally very safe and well-tolerated, it does have a few potential side effects [13]. Some people experience stomach issues such as nausea, abdominal cramps, or diarrhea [12]. Additionally, the breakdown of L-carnitine in the gut can sometimes cause a “fishy” body odor [14]. If you experience these side effects, do not simply stop taking the medication. Instead, talk to your doctor—side effects can often be managed by splitting the dose throughout the day, adjusting the prescription, or taking the supplement with meals.

Essential Medical Screening

Because the hidden risks of SPCD primarily involve the heart, it is critical for all newly diagnosed individuals—even those without symptoms—to undergo thorough cardiac screening [3][7].

Your doctor should order:

  • Echocardiogram: An ultrasound of your heart to check for signs of weakening or enlargement (cardiomyopathy) [3][7].
  • Electrocardiogram (EKG/ECG): A test that measures the electrical activity of your heart to identify dangerous rhythms, such as short QT syndrome [7][2].

Before making any decisions about declining or stopping L-carnitine therapy, it is very important to consult with a metabolic specialist (a doctor who specializes in genetic disorders affecting the body’s chemistry) or a geneticist [1]. They can evaluate your specific carnitine levels, interpret your cardiac screening results, and help you understand your individual risks.

Finally, because SPCD is genetic, your parents, siblings, and other family members should also be informed so they can consider getting tested [6].

Common questions in this guide

Why do I need L-carnitine treatment for SPCD if I feel perfectly healthy?
Even without symptoms, untreated SPCD carries a high risk of sudden cardiac death, cardiomyopathy, and dangerous arrhythmias. Lifelong L-carnitine supplementation replenishes your levels and prevents these silent but severe heart complications.
What triggers SPCD heart problems in adults with no symptoms?
Heart complications can strike without warning during times when your body requires extra energy. Common triggers include severe illness, fasting, emotional stress, pregnancy, or intense physical activity.
What cardiac tests do I need after an SPCD diagnosis?
Even if you feel fine, you should have a thorough heart evaluation. This typically includes an echocardiogram to check for a weakened or enlarged heart and an electrocardiogram (EKG) to look for dangerous electrical rhythms.
How do I manage the side effects of L-carnitine supplements?
If you experience nausea, diarrhea, or a fishy body odor, do not stop your medication. Talk to your doctor about splitting your dose throughout the day, taking it with meals, or adjusting your prescription.
Do my family members need to be tested for SPCD?
Yes, because SPCD is an inherited genetic disorder, your parents, siblings, and other biological family members may also be at risk. You should inform them of your diagnosis so they can discuss testing with their doctors.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you refer me to a metabolic specialist to discuss my SPCD diagnosis and treatment plan?
  2. 2.What specific cardiac tests, such as an EKG and echocardiogram, should I have right now to check the health of my heart?
  3. 3.What dosage of L-carnitine is appropriate for me given that I am currently asymptomatic?
  4. 4.Are there any intense exercises or activities I should avoid while we wait for my cardiac screening results?
  5. 5.How often will we need to monitor my blood carnitine levels and check my heart health going forward?
  6. 6.What is the best way to manage side effects like stomach upset or body odor if I experience them while taking L-carnitine?
  7. 7.Should my family members (such as parents or siblings) be tested for SPCD, and how do we coordinate that?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Increased risk of sudden death in untreated primary carnitine deficiency.

    Rasmussen J, Dunø M, Lund AM, et al.

    Journal of inherited metabolic disease 2020; (43(2)):290-296 doi:10.1002/jimd.12158.

    PMID: 31373028
  2. 2

    Molecular Autopsy Implicates Primary Carnitine Deficiency in Sudden Unexplained Death and Reversible Short QT Syndrome.

    Gélinas R, Leach E, Horvath G, Laksman Z

    The Canadian journal of cardiology 2019; (35(9)):1256.e1-1256.e2 doi:10.1016/j.cjca.2019.05.014.

    PMID: 31472821
  3. 3

    Primary carnitine deficiency - diagnosis after heart transplantation: better late than never!

    Grünert SC, Tucci S, Schumann A, et al.

    Orphanet journal of rare diseases 2020; (15(1)):87 doi:10.1186/s13023-020-01371-2.

    PMID: 32276632
  4. 4

    Primary carnitine deficiency in a 57-year-old patient with recurrent exertional rhabdomyolysis.

    Echaniz-Laguna A, Biancalana V, Gaignard P, Chanson JB

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-224272.

    PMID: 29895548
  5. 5

    A newborn with seizures born to a mother diagnosed with primary carnitine deficiency.

    Chen S, Hu Y, Huang Y, et al.

    BMC pediatrics 2019; (19(1)):79 doi:10.1186/s12887-019-1452-4.

    PMID: 30885166
  6. 6

    Molecular investigation in Chinese patients with primary carnitine deficiency.

    Zhang Y, Li H, Liu J, et al.

    Molecular genetics & genomic medicine 2019; (7(9)):e901 doi:10.1002/mgg3.901.

    PMID: 31364285
  7. 7

    Systemic primary carnitine deficiency induces severe arrhythmia due to shortening of QT interval.

    Lodewyckx P, Issa J, Gaschignard M, et al.

    Molecular genetics and metabolism 2023; (140(4)):107733 doi:10.1016/j.ymgme.2023.107733.

    PMID: 37979236
  8. 8

    Systemic primary carnitine deficiency with hypoglycemic encephalopathy.

    Jun JS, Lee EJ, Park HD, Kim HS

    Annals of pediatric endocrinology & metabolism 2016; (21(4)):226-229 doi:10.6065/apem.2016.21.4.226.

    PMID: 28164076
  9. 9

    Left ventricular noncompaction cardiomyopathy and short QT syndrome due to primary carnitine deficiency.

    Hanington OP, Armstrong C, Pierre G, et al.

    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2023; (28(6)):e13077 doi:10.1111/anec.13077.

    PMID: 37658577
  10. 10

    A case of atypical systemic primary carnitine deficiency in Saudi Arabia.

    Alghamdi A, Almalki H, Shawli A, et al.

    Pediatric reports 2018; (10(2)):7705 doi:10.4081/pr.2018.7705.

    PMID: 30069296
  11. 11

    A Moderate Carnitine Deficiency Exacerbates Isoproterenol-Induced Myocardial Injury in Rats.

    Giudice PL, Bonomini M, Arduini A

    Cardiovascular drugs and therapy 2016; (30(2)):119-27 doi:10.1007/s10557-016-6647-4.

    PMID: 26838729
  12. 12

    L-carnitine reduces hospital admissions in patients with hepatic encephalopathy.

    Tani J, Morishita A, Sakamoto T, et al.

    European journal of gastroenterology & hepatology 2021; (32(2)):288-293 doi:10.1097/MEG.0000000000001748.

    PMID: 32925502
  13. 13

    Efficacy and safety of carnitine supplementation on NAFLD: a systematic review and meta-analysis.

    Liu A, Cai Y, Yuan Y, et al.

    Systematic reviews 2023; (12(1)):74 doi:10.1186/s13643-023-02238-w.

    PMID: 37120548
  14. 14

    L-Carnitine Supplementation Increases Trimethylamine-N-Oxide but not Markers of Atherosclerosis in Healthy Aged Women.

    Samulak JJ, Sawicka AK, Hartmane D, et al.

    Annals of nutrition & metabolism 2019; (74(1)):11-17 doi:10.1159/000495037.

    PMID: 30485835

This page explains Systemic Primary Carnitine Deficiency (SPCD) treatment for educational purposes only. Always consult your metabolic specialist or geneticist regarding your specific medication and cardiac screening needs.

Get notified when new evidence is published on Systemic primary carnitine deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.